Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Merck obtains rights to novel drug screening technology

Feb. 19, 1998

New antiproliferative compounds patented by Warner-Lambert

Feb. 18, 1998

Novel VEGF inhibitors in development at Genentech

Feb. 18, 1998

Antimetastatic properties of ND-2001, a nojirimycin derivative

Feb. 18, 1998

Tyrosine kinase modulators under development by Yissum, Sugen

Feb. 18, 1998

Femara: second-line treatment option for advanced breast cancer

Feb. 17, 1998

Warner-Lambert reveals new protein farnesyltransferase inhibitors

Feb. 17, 1998

New GnRH antagonists from Merck & Co.

Feb. 17, 1998

Progenitor discovers novel angiogenesis gene

Feb. 16, 1998

Nonpeptide GnRH antagonists disclosed by Merck & Co.

Feb. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...